Together, results from Fig. 3 suggest that AR may function through modulation of the VEGF-A or VEGF-C in ccRCC cells to differentially influence the hematogenous and the lymphatic endothelial cells, thus ultimately affect different metastatic destinations. This evidence concerns the gene VEGFC and nonpapillary renal cell carcinoma.